SARA KOENIG: Open Payments
NPI 1336478007 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 21 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $652 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $70 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $65 |
| Amgen Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $51 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Organon LLC | 1 | $25 |
| Evofem Biosciences, Inc. | 1 | $20 |
| MILLICENT US INC | 1 | $20 |
| OptumHealth Care Solutions, LLC | 1 | $18 |
Products named: Veozah, EVENITY, UBRELVY, MYFEMBREE, Mirena, NEXPLANON, Phexxi, FEMLYV.
Industry payments across MO — which companies pay providers there.
